Aims and scope of journal
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels. Learn more about the journal here.
Why publish with Molecular Psychiatry?
Ranked in the top 10 Psychiatry journals, we aim to elucidate the biological mechanisms underlying psychiatric disorders and their treatment.
With an international reputation for high-impact research in Psychiatry and Neurosciences, our emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging, and psychopharmacology levels.
In addition to publishing original articles, we also feature news and commentary, reviews, and immediate communications.
Our publishing models
Molecular Psychiatry is a Transformative Journal (TJ). When research is accepted for publication, authors can choose to publish using either the traditional publishing route OR via immediate gold Open Access.
Molecular Psychiatry is actively committed to becoming a fully Open Access journal. We will increase the number of articles we publish OA, with the eventual goal of becoming a fully Open Access journal. A journal that commits to this process is known as a Transformative Journal.
Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route our standard licensing terms will need to be accepted including our self-archiving policies. Those standard licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
22 days from submission to 1st decision
144 days from submission to acceptance
17 days from acceptance to publication
The 2020 journal citation metrics for Molecular Psychiatry are as follows:
2-year Impact Factor*: 15.992
5-year Impact Factor*: 14.806
Immediacy index*: 5.004
Eigenfactor® score*: 0.04622
Article influence score*: 4.999
JCR Rank*: BIOCHEMISTRY & MOLECULAR BIOLOGY 11/298; PSYCHIATRY 6/156; NEUROSCIENCES 6/273
Journal Citation Score*: 3.21
*2020 Journal Citation Reports® Science Edition (Clarivate Analytics, 2020)
Current Contents/Life Sciences
Neuroscience Citation Index
Science Citation Index
Science Citation Index Expanded
ISSN and eISSN
The international standard serial number (ISSN) for Molecular Psychiatry is 1359-4184 and the electronic international standard serial number (eISSN) is 1476-5578.
Molecular Psychiatry now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.
Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Nature Publishing Group.